Bill · H.R. 8939· House(119-HR-8939)

Closing the HPV Testing Gap Act

Age: 40 years

New Jersey

Introduced: 5/20/2026
Last activity: 5/20/2026 — Referred to the House Committee on Energy and Commerce.
Sponsored by: LaMonica McIver
Cosponsors: - 20 - 0

Health

Introduced
In Committee

What this bill would do

The Closing the HPV Testing Gap Act directs the Director of the National Institutes of Health to study the development of a standardized, noninvasive HPV test for men. The Director must coordinate with agencies like the FDA and CDC and consult with clinical experts. The study will assess current research, test methodologies, and the feasibility of testing in diverse populations. Within 30 months of enactment, the Director must submit a report to Congress with findings and recommendations. The goal is to address the lack of an FDA-approved HPV diagnostic test for men.

Yes· 3 of 22

Would men be better off under this?+9
Directly addresses the lack of FDA-approved HPV diagnostic tests for men to prevent cancer.
Would people in middle age be better off under this?+6
Improves cancer prevention and detection for men at higher risk ages.
Does this narrow the gap between how men and women are treated?+6
Specifically aims to promote gender equity in cancer prevention by expanding detection to men.